Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-005279-32Phase 3Completed
Phase 3, randomised, open-label trial in Intracranial mass lesion (IML) comparing Sevoflurane + fentanyl, Propofol + fentanyl and Sevoflurane + remifentanil (3 arms). Primary endpoint: Time to modified Aldrete score at least 9. Started Oct 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-005279-32.